Corrado Advisors’s Pfizer PFE Stock Holding History

Corrado Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-70,974	Closed	-$1.88M	–	111
2024 Q4	$1.88M	Buy	70,974 +9,357	+15%	+$254K	1.23%	33
2024 Q3	$1.78M	Sell	61,617 -1,928	-3%	-$56.2K	1.12%	40
2024 Q2	$1.78M	Sell	63,545 -4,372	-6%	-$120K	1.15%	39
2024 Q1	$1.88M	Buy	67,917 +6,209	+10%	+$172K	1.24%	36
2023 Q4	$1.78M	Sell	61,708 -9,515	-13%	-$288K	1.45%	32
2023 Q3	$2.36M	Buy	71,223 +590	+0.8%	+$20.9K	1.63%	16
2023 Q2	$2.59M	Buy	70,633 +826	+1%	+$32.1K	1.81%	14
2023 Q1	$2.85M	Buy	69,807 +1,961	+3%	+$84.7K	1.89%	6
2022 Q4	$3.48M	Buy	67,846 +1,815	+3%	+$87K	2.43%	2
2022 Q3	$2.89M	Sell	66,031 -554	-0.8%	-$26.9K	2.35%	5
2022 Q2	$3.49M	Sell	66,585 -1,852	-3%	-$94.4K	2.48%	3
2022 Q1	$3.54M	Sell	68,437 -1,085	-2%	-$56.3K	2.17%	8
2021 Q4	$4.11M	Sell	69,522 -2,552	-4%	-$126K	2.46%	8
2021 Q3	$3.1M	Buy	72,074 +1,334	+2%	+$59.1K	1.92%	15
2021 Q2	$2.77M	Buy	70,740 +20,315	+40%	+$790K	1.71%	15
2021 Q1	$1.83M	Buy	50,425 +140	+0.3%	+$4.97K	1.35%	24
2020 Q4	$1.85M	Sell	50,285 -895	-2%	-$32.8K	1.43%	24
2020 Q3	$1.78M	Buy	51,180 +9,101	+22%	+$319K	1.48%	20
2020 Q2	$1.3M	Buy	42,079 +32,113	+322%	+$1.09M	1.18%	25
2020 Q1	$308K	Hold	9,966	–	–	0.29%	54
2019 Q4	$370K	Buy	9,966 +570	+6%	+$20.3K	0.33%	51
2019 Q3	$320K	Hold	9,396	–	–	0.29%	62
2019 Q2	$386K	Buy	9,396 +4,416	+89%	+$175K	0.35%	50
2019 Q1	$201K	Hold	4,980	–	–	0.18%	69
2018 Q4	$206K	Sell	4,980 -590	-11%	-$24.5K	0.2%	73
2018 Q3	$233K	Buy	+5,570	New	+$214K	0.15%	85
2018 Q2	–	Sell	-8,884	Closed	-$299K	–	115
2018 Q1	$299K	Sell	8,884 -31,272	-78%	-$1.08M	0.18%	88
2017 Q4	$1.38M	Sell	40,156 -137	-0.3%	-$4.67K	0.81%	39
2017 Q3	$1.36M	Sell	40,293 -225	-0.6%	-$7.23K	0.77%	37
2017 Q2	$1.29M	Buy	40,518 +58	+0.1%	+$1.83K	0.71%	42
2017 Q1	$1.31M	Buy	40,460 +717	+2%	+$22.6K	0.75%	37
2016 Q4	$1.23M	Buy	39,743 +2,001	+5%	+$61.1K	0.76%	34
2016 Q3	$1.21M	Buy	37,742 +869	+2%	+$29.1K	0.77%	35
2016 Q2	$1.23M	Sell	36,873 -264	-0.7%	-$8.43K	0.8%	34
2016 Q1	$1.04M	Buy	37,137 +1,054	+3%	+$30.1K	0.67%	36
2015 Q4	$1.1M	Buy	36,083 +11	+0%	+$346	0.65%	37
2015 Q3	$1.07M	Hold	36,072	–	–	0.61%	40
2015 Q2	$1.15M	Hold	36,072	–	–	0.52%	43
2015 Q1	$1.19M	Hold	36,072	–	–	0.51%	34
2014 Q4	$1.07M	Buy	36,072 +18	+0%	+$516	0.52%	27
2014 Q3	$1.01M	Hold	36,054	–	–	0.45%	35
2014 Q2	$1.01M	Sell	36,054 -227	-0.6%	-$6.47K	0.44%	31
2014 Q1	$1.11M	Sell	36,281 -607	-2%	-$18.1K	0.54%	29
2013 Q4	$1.07M	Sell	36,888 -1,821	-5%	-$53K	0.48%	29
2013 Q3	$1.05M	Buy	+38,709	New	+$1.05M	0.55%	25

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corrado Advisors's PFE Position: Q1 2025 in Review

Corrado Advisors sold out of Pfizer (PFE) in Q1 2025, closing a stake of 70,974 shares — an estimated $1.88M sold.

Corrado Advisors first reported a position in PFE in Q3 2013 and held it in 45 quarters. The position peaked at $4.11M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Corrado Advisors reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Corrado Advisors sold 70,974 Pfizer shares in Q1 2025, an estimated $1.88M.
Corrado Advisors first reported a position in Pfizer in Q3 2013 and held it in 45 quarters.
Corrado Advisors's Pfizer position peaked at $4.11M in Q4 2021.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Corrado Advisors's 13F filing for Q1 2025, filed 1 May 2025.